ODAC Votes in Favor of Continued Development of Dostarlimab for dMMR/MSI-H Locally Advanced Rectal Cancer

“I voted yes,” Christopher Lieu, MD, co-director, GI Medical Oncology Program and associate director for clinical research, at the University of Colorado Cancer Center, said.